CDCN team crafted a 6-phase project plan and spent 2 years executing it: stakeholder identification, survey & data analysis, interviews, qualitative data analysis, and tool development. We couldn't do it without the active participation of the rare disease community!

Global Remote Research Scholars Program - GRRSP is excited to announce another high value publication ✅ 👇 Authored by Dr.Gowthami_Jagirdhar @doxycyclinitin Rakhtan Qasba @haoirse_ in collaboration with CURE ID Rahul Kashyap, MD, MBA 🇺🇸🇮🇳 mschito 🙏🥳😇

Love this! #castlemanflex #warriorflex !

Great to hear David Fajgenbaum, MD's journey from #RareDisease patient to innovator in #DrugRepurposing leading Every Cure. This week, REMEDi4ALL is at the Critical Path Institute (C-Path)'s Drug Repurposing event in the US. It's exciting to share best practices with global peers!

At the Critical Path Institute (C-Path) /cdrc meeting yesterday, c-path.org/april-18-20-20…, I picked up this tip for treating #nausea: aliem.com/trick-trade-is… More sessions on #DrugRepurposing and rare #Cancer today at 1, linked above.

What a great event put on by Critical Path Institute (C-Path)'s CDRC team. As a communicator, I have a lot to learn about the scientific and medical contributions our organization and focus groups make. And I sure did, about the value and importance of drug repurposing. Truly life-saving work.

The EHE Foundation is grateful for the opportunity to partner with the CURE Drug Repurposing Collaboratory (CDRC). For more information, visit: c-path.org/programs/cdrc/ CURE ID #EHEresearch #fightEHE #EHEawarenessmonth #EHE #EHEfoundation #EHEcancer

Ushering in more precision for sarcoma treatment. We need to learn from prior trials that failed. This is a great opportunity for the field to come together. Many thanks Dr. Tap for sharing your vision.

Deadly Fungal Infections Confound Doctors: ‘It’s Going to Get Worse’ Once a freak occurrence, fungi resistant to standard drugs now threaten millions of Americans With quotes from FungalDoc: moved to bluesky Patrick Bryan Peter G Pappas Tom Chiller George Thompson Fariba Donovan wsj.com/articles/deadl…

Dr. Marco Schito (mschito), Executive Director of CDRC at Critical Path Institute (C-Path), will be a guest lecturer for the Celdara Medical High-Potential Entrepreneurs' Fellowship (CHEF) Program. His lecture will offer valuable insights into challenges & opportunities of drug repurposing.

Found this artifact moving offices today. Anyone know what it was used for??

🎧 Listen to FDA’s Heather Stone and #CPath’s Dr. Marco Schito (mschito) discuss exciting new developments on CURE ID app that allows the global community to report novel uses of existing drugs for difficult-to-treat diseases: fda.gov/media/170476/d…

So exciting to see our podcast on #CUREID and #CDRC featured on Q&A with #FDA about #drug #repurposing for difficult-to-treat #diseases. Podcast available at: fda.gov/media/170476/d… U.S. FDA FDA Drug Information FDA Global FDA Oncology FDAWomen NCATS NIH Critical Path Institute (C-Path)

#CTOS2023 Ultra-rare #sarcomas session underscored the vital importance and urgent need for collaboration among sarcoma communities, highlighting the crucial role of working together in this field. William Tap Liz Connolly Silvia Stacchiotti Anna Maria Frezza CTOS

Irish dance & trad at #CTOS2023 #CTOStweeTOS

If you didn’t know, CURE ID is expanding to rare and ultra rare cancers to collect drug repurposing and treatment information. We are currently attending #CTOS23 to learn more from the #sarcoma and patient advocacy community! We look forward to future collaboration.

Critical Path Institute (C-Path) ‘s CURE Drug Repurposing Collaboratory is taking part in the PUSH project (Pushing Ultra-Rare Sarcomas Beyond Hope – International Trial ). We look forward to this collaboration and working on this important project #CTOS2023 #UltraRareSarcoma

Thank you to SPAGN for hosting the advocacy lounge CTOS. We have been able to connect and speak with advocates in the sarcoma community #CTOS23 #Sarcoma please reach out if you would like to connect

We urge Member States to: 🔸 support development of treatment options for people with advanced #HIV, including paediatric formulations #AHD 🔸 take urgent actions to remove barriers to #hepatitisC diagnosis and treatment 📖 Read our #WHA77 intervention: dndi.org/statements/202…

Check out the World Health Organization (WHO)’s recent news about CURE ID titled “Progress update on the WHO–US FDA collaborative project on the review and use of online repository for difficult-to-treat infections” who.int/news/item/30-0…